These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923 [TBL] [Abstract][Full Text] [Related]
23. [Treatment of some chronic hemoblastoses by a derivative of methylhydrazine (Natulan)]. Quattrin N; Montuori R Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):178-9. PubMed ID: 4968995 [No Abstract] [Full Text] [Related]
24. Results of clinical study antitumor action of hydrazine sulfate. Gershanovich ML; Danova LA; Ivin BA; Filov VA Nutr Cancer; 1981; 3(1):7-12. PubMed ID: 7050922 [No Abstract] [Full Text] [Related]
25. Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy. Klener P; Donner L; Roth Z Neoplasma; 1976; 23(3):315-22. PubMed ID: 958533 [TBL] [Abstract][Full Text] [Related]
26. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
27. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)]. Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465 [No Abstract] [Full Text] [Related]
28. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases]. da Silva MP; Kerbauy J; de Guerra CC Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416 [No Abstract] [Full Text] [Related]
29. [Use of a methyl hydrazine derivative in the treatment of Hodgkin's disease]. Hollard D; Schaerrer R Lyon Med; 1966 Apr; 215(17):1167-74. PubMed ID: 5930371 [No Abstract] [Full Text] [Related]
30. Advances in the pharmacology of cancer chemotherapy. Smith SD Pediatr Clin North Am; 1981 Feb; 28(1):145-60. PubMed ID: 6259577 [No Abstract] [Full Text] [Related]
31. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative]. Zarrilli D; Perrone V; Pergola M Clin Ter; 1966 Oct; 39(2):123-36. PubMed ID: 4871417 [No Abstract] [Full Text] [Related]
33. [Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma]. Con I; Daiber A; Donoso A; Osorio G; Mora F Rev Med Chil; 1972 Apr; 100(4):408-13. PubMed ID: 4557485 [No Abstract] [Full Text] [Related]
34. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. Kosty MP; Fleishman SB; Herndon JE; Coughlin K; Kornblith AB; Scalzo A; Morris JC; Mortimer J; Green MR J Clin Oncol; 1994 Jun; 12(6):1113-20. PubMed ID: 8201372 [TBL] [Abstract][Full Text] [Related]
35. [First clinical experiences with methylhydrazine in treatment of malignant lymphogranuloma]. Fazio M; Cavallero P; Sartoris S; Vergnano F; Pegoraro L Minerva Med; 1965 Dec; 56(99):4338-43. PubMed ID: 5323491 [No Abstract] [Full Text] [Related]
36. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study. Weick JK; Jones SE; Haut A; Fisher R; Dixon D Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373 [TBL] [Abstract][Full Text] [Related]